Loading...
XJPX
4921
Market cap0kUSD
Dec 17, Last price  
2,790.00JPY
Name

Fancl Corp

Chart & Performance

D1W1MN
XJPX:4921 chart
P/E
0.00
P/S
0.00
EPS
2,944,333,333.33
Div Yield, %
Shrs. gr., 5y
-0.92%
Rev. gr., 5y
-1.97%
Revenues
110.88b
+7.03%
87,937,000,00095,322,000,000101,065,000,00099,349,000,00098,004,000,00099,536,000,00093,789,000,00088,165,000,00082,807,000,00081,118,000,00077,632,000,00090,850,000,00096,305,000,000109,019,000,000122,496,000,000126,810,000,000114,909,000,000103,992,000,000103,595,000,000110,881,000,000
Net income
8.83b
+77.73%
1,709,000,0005,183,000,0002,547,000,0003,694,000,0002,662,000,0004,306,000,0002,849,000,0002,454,000,000-2,193,000,0001,343,000,0002,301,000,000522,000,0005,146,000,0006,191,000,0008,649,000,0009,985,000,0008,016,000,0007,421,000,0004,970,000,0008,833,000,000
CFO
11.32b
-12.58%
4,637,000,0009,162,000,0006,472,000,0007,379,000,0006,005,000,00010,531,000,0006,311,000,0006,321,000,0006,145,000,0006,595,000,0005,946,000,0003,170,000,0002,192,000,00010,531,000,0008,731,000,00014,380,000,00010,011,000,00013,097,000,00012,952,000,00011,323,000,000
Dividend
Mar 28, 20250 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fancl Corporation engages in the manufacture and sale of cosmetics and dietary supplements. The company provides cosmetics, quasi-drugs, nutritional supplements, and other products in Japan and internationally. It also offers germinated brown rice and kale juice products; develops and distributes undergarments and fashion goods; and distributes cosmetics and nutritional supplements. In addition, the company operates as an insurance agency. It sells its products through online and catalogue, direct store, and wholesale channels. The company was founded in 1980 and is headquartered in Yokohama, Japan.
IPO date
Dec 07, 1999
Employees
1,281
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT